Collection 5 (Sep 2024 - Aug 2025) Articles

Articles
LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention
Li J, Yan K, Zhu P, et al.
Journal:
Clin Cardiol

First published: October 21, 2024 DOI: 10.1002/clc.70025
View
- Share
Articles
Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease
Shah NP, Mulder H, Lydon B, et al.
Journal:
Am Heart J

First published: October 16, 2024 DOI: 10.1016/j.ahj.2024.10.009
View
- Share
Articles
Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation
Nicholls SJ, Manmathan GP
Journal:
Atherosclerosis

First published: October 11, 2024 DOI: 10.1016/j.atherosclerosis.2024.118628
View
- Share
Articles
Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
Carvalho PEP, Gewehr DM, Nascimento BR, et al.
Journal:
JAMA Cardiol

First published: October 9, 2024 DOI: 10.1001/jamacardio.2024.3216
View
- Share
Articles
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
Fuster V, García-Álvarez A, Devesa A, et al.
Journal:
J Am Coll Cardiol

First published: October 8, 2024 DOI: 10.1016/j.jacc.2024.06.045
View
- Share
Articles
Within-person stability of lipoprotein(a) concentration
Ghouse J, Ahlberg G, Albertsen Rand S, et al.
Journal:
Eur Heart J

First published: October 8, 2024 DOI: 10.1093/eurheartj/ehae652
View
- Share
Articles
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)
Journal:
Lancet Diabetes Endocrinol

First published: October 3, 2024 DOI: 10.1016/S2213-8587(24)00221-3
View
- Share
Articles
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
Zahger D, Schwartz GG, Du W, et al.
Journal:
J Am Coll Cardiol

First published: September 10, 2024 DOI: 10.1016/j.jacc.2024.06.035
View
- Share
Articles
Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial
Gibson CM, Duffy D, Bahit MC, et al.
Journal:
Eur Heart J

First published: September 2, 2024 DOI: 10.1093/eurheartj/ehae614
View
- Share
Articles
Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
Schubert J, Leosdottir M, Lindahl B, et al.
Journal:
Eur Heart J

First published: September 1, 2024 DOI: 0.1093/eurheartj/ehae576
View
- Share
Articles
Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world
De Geest B, Van Linthout S
Journal:
Eur Heart J

First published: September 1, 2024 DOI: 10.1093/eurheartj/ehae577
View
- Share

Collection 5 (Sep 2024 - Aug 2025) Articles

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Articles

Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome

Zahger D, Schwartz GG, Du W, et al.

Articles

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial

Gibson CM, Duffy D, Bahit MC, et al.

Articles

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Schubert J, Leosdottir M, Lindahl B, et al.

Articles

Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world

De Geest B, Van Linthout S

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Share

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Share

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Share

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Share

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Share

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Share

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Share

Articles

Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome

Zahger D, Schwartz GG, Du W, et al.

Share

Articles

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial

Gibson CM, Duffy D, Bahit MC, et al.

Share

Articles

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Schubert J, Leosdottir M, Lindahl B, et al.

Share

Articles

Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world

De Geest B, Van Linthout S

Share